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Supplemental Materials and Methods 
Enzymes and Reagents   
ClaI, EcoRI, T4 polynucleotide kinase and Klenow fragment (3’5’ exo-) were purchased from 
New England Biolabs. Terminal deoxynucleotidyl transferase and Pfu Turbo polymerase were 
purchased from Amersham and Stratagene respectively. ATP was purchased from Sigma and 
dissolved as a concentrated stock at pH 7. The concentration of the stock solution was 
determined using extinction coefficient of 15,400 M-1cm-1. [-32P]-dATP (3000 Ci/mmol) and 
[-32P]-ATP (6000 Ci/mmol) were purchased from NEN Biochemicals. Proteinase K was 
purchased from Roche.  
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DNA and Proteins 
Plasmid DNA (pUC19) was purified using a protocol that used lysis at a neutral pH followed by 
cesium chloride density gradient centrifugation (Sambrook et al. 1989). Its concentration was 
determined using an extinction coefficient of 6.6 x 103 M-1cm-1. Oligodeoxyribonucleotides X12-
3 (GACGTCATAGACGATTACATTGCTAGGACATGCTGTCTAGAGACTATCGC), X12-
3SC (TTGCTAGGACATGCTGTCTAGAGACTATCGC), X12-4C 
(GCGATAGTCTCTAGACAGCATGTCCTAGCAATGTAATCGTCTATGACGTC), 
X124NC 
(GCGATAGTCTCTAGACAGCATGTCCTAGCAAGCCAGAATTCGGCAGGCTA), 
 AA03 (ACTCGAATTCCTCGAGGTCCCTTTATGGTCCC) and AA04 
(CTGTGAATTCAAGCTTATCGATACCGTCACACCA) were synthesized by Sigma and 
purified by 20% polyacrylamide gel electrophoresis. Their concentrations were determined using 
extinction coefficients of 4.84 x 103, 2.95 x 103, 4.83 x 103, 4.88 x 103, 2.89 x 103 and 3.26 x 103 
M-1cm-1 respectively. The oligonucleotides were 32P-labeled at the 5’-ends (using [-32P]-ATP 
and T4 polynucleotide kinase) or 3’-ends (using [-32P]-dATP and terminal deoxynucleotidyl 
transferase) according to vendor’s protocol. The MRN complex (van der Linden et al. 2009), 
BLM (Nimonkar et al. 2008), Sgs1 (Cejka and Kowalczykowski 2010), E. coli RecQ (Harmon 
and Kowalczykowski 1998), DNA2 (wild type, K671E and D294A mutants) (Kim et al. 2006; 
Masuda-Sasa et al. 2006), Dna2 (Cejka et al. 2010), E. coli RecJ (Handa et al. 2009), EXO1 
(wild type  and D173A nuclease mutant) (Genschel et al. 2002; Dzantiev et al. 2004), human 
RPA (Walther et al. 1999), S. cerevisiae RPA (Kantake et al. 2003), and E. coli SSB (Harmon 
and Kowalczykowski 1998) were purified according to published protocols. To ensure that the 
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BLM and RPA preparations were free of contaminating nucleases, the proteins were incubated 
with 32P-labeled 50-mer ssDNA and 50-bp dsDNA at molar concentrations that were ~50 fold 
higher than the DNA concentration (molecules); in the standard buffer and for standard 
incubation times, no nucleolytic degradation of the DNA was detected using denaturing gel 
electrophoresis. Human RecQ4, RecQ5, WRN, and BLM helicase mutant (K695R) were gifts 
from Patrick Sung (Yale University), Ian Hickson (University of Oxford, UK), Davis Chen (UT 
Southwestern) and Alex Mazin (Drexel University), respectively.  
 
Substrates for nuclease assays   
A 5’-end 32P-labeled blunt-ended substrate (50 nucleotides (nt) long) was generated by annealing 
oligodeoxyribonucleotides X12-3 (32P-labeled at 5’-end) and X12-4C which are completely 
complementary. A 3’-end 32P-labeled blunt-ended substrate was generated similarly by annealing 
X12-3 and X12-4C (32P-labeled at 3’-end). A 5’-end 32P-labeled forked substrate (50 nt long, 
with 19 bases unpaired and 31 paired bases) was generated by annealing X12-3 (32P-labeled at 
5’-end) and X12-4NC, which are partially complementary. A 3’-end 32P-labeled forked substrate 
was generated similarly by annealing X12-3 and X12-4NC (32P-labeled at 3’-end). A 5’-end 32P-
labeled 3’-tailed substrate (50 nt long, 19 bases overhang and 31 paired bases) was generated by 
annealing X12-3SC (32P-labeled at 5’-end) and X12-4C. Similarly, a 3’-end 32P-labeled 3’-tailed 
substrate was generated by annealing X12-3SC and X12-4C (32P labeled at 3’ end). Annealing 
was performed as described previously (Cejka and Kowalczykowski 2010). EcoRI linearized 
pUC19 (2.7 kbp) was 32P-labeled at the 5’-ends (using [-32P]-ATP and T4 polynucleotide 
kinase) or 3’-ends (using [-32P]-dATP and Klenow fragment) according to the vendor’s 
protocol. A 324 bp DNA fragment derived from the yeast RAD51 gene promoter was generated 
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by PCR using Pfu Turbo polymerase as previously described (Alexeev et al. 2003) with the 
exception that the primers (AA03 and AA04) had EcoRI sites (indicated in italics). The 
amplification product was purified using Qiagen PCR cleanup kit. To label the fragment at the 
ends, the amplified product was first digested with EcoRI. EcoRI digested PCR fragment was 
32P-labeled at the 5’-ends (using [-32P]-ATP and T4 polynucleotide kinase) or 3’-ends (using 
[-32P]-dATP and Klenow fragment) according to the vendor’s protocol. After every 
radiolabeling reaction, the unincorporated nucleotides were separated from the labeled product 
using a G-25 spin column (GE). The concentration of the labeled product was determined by 
assuming ~95% recovery from G-25 spin column. DNA concentrations of the substrates are 
expressed in molar ends as well as nt. Schematic representations of the substrates are drawn on 
top of each figure. Red asterisk indicate position of 32P on DNA ends. 
 
EXO1 processivity assays 
Reactions were performed at 37 °C and contained 1.2 nM gapped circular dsDNA (6.44 kb, gap 
size 314 nt (f1MR1 coordinates 6127-6440) and 5 mM MgCl2. Reactions were done in the 
absence of ATP. Where indicated, BLM concentration was 20 nM. Reactions were started by 
addition of EXO1 to a concentration of 1.1 nM. To test for excision complex formation, f1MR1 
ssDNA was added to a concentration of 6 nM molecules (38 M nt) either 1 min after start of the 
reaction or at the start of the reaction. Reactions were stopped by the addition of 2 g/l 
Proteinase K and 1% SDS (final concentrations) and incubated for 30 min. DNA was recovered 
by ethanol precipitation after phenol extraction, digested with ClaI, electrophoresed under 
alkaline conditions, and transferred to nylon membrane (Hybond XL, GE Healthcare) as 
described (Genschel and Modrich 2003). Recession of the 5’ end was detected by probing the 
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membranes with 32P-labeled oligonucleotides hybridizing near the ClaI site (coordinates 2532-
2552).The assay to determine the effect of MRN (20 nM) on the processivity of EXO1 (1 nM) 
was performed using a similar strategy with the exception that the standard nuclease assay with 
2.7 kbp 3’-end 32P-labeled DNA was used for analysis, and the competitor DNA was X ssDNA 
(6 nM molecules, 32 M nt).  
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Supplemental Figure Legends 
 
Figure S1. BLM helicase requires RPA for unwinding activity, is blocked at higher 
concentrations of Mg2+ and the polarity of resection by BLM and DNA2 is 5’3’.  
Helicase reactions with BLM were performed using 3’-end labeled 2.7 kbp DNA. 
(A) Requirement for RPA: All reactions contained 2 mM MgCl2. Lanes 1-5: 0, 200, 400 and 800 
nM RPA; substrate; , heat-denatured substrate.  
(B) The percentage of dsDNA unwound (obtained by expressing the amount of DNA unwound 
as a percentage of total signal) from experiments as shown in (A) plotted as a function of RPA 
concentration. 
(C) Mg2+ concentration dependence: All reactions contained 400 nM RPA. Lanes: , heat-
denatured substrate; 1-5: 0, 1, 2, 5 and 10 mM MgCl2.  
(D) The percentage of dsDNA unwound (obtained by expressing the amount of DNA unwound 
as a percentage of total signal) from experiments as shown in (C) plotted as a function of Mg2+ 
concentration.  
The positions of intact (2.7 kbp) and unwound (ssDNA) substrate (A and C) are indicated. Error 
bars (B and D) indicate standard deviation between 3 to5 independent experiments and are 
smaller than the symbols when not evident. 
(E) and (F) Kinetics of resection.  
(E) Nuclease reactions were performed using 3’-end labeled 2.7 kbp DNA. Lanes: 1-4, BLM; 5-
8, BLM and DNA2; 9, DNA2; , heat-denatured substrate. The positions of intact (2.7 kbp) and 
unwound (ssDNA) substrate, resection products, and molecular weight markers are indicated.  
(F) Nuclease reactions were performed using 5’- or 3’-end labeled 324-bp DNA. All reactions 
contained 50 nM RPA and 2 mM MgCl2. Lanes: 1-5, 5’-end labeled DNA; 6-10, 3’-end labeled 
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DNA. The positions of intact substrate (324 bp), resection products and contaminants in the PCR 
product (asterisk) are indicated. 
Figure S2. The polarity of cleavage by DNA2 is 5’  3’. 
(A) Nuclease reactions were performed as described in Figure 1B with the exception that 
products were resolved on a 12% urea-polyacrylamide gel. All reactions contained 10 nM RPA 
and 5 mM MgCl2. Lanes: 1, forked substrate; 2, forked substrate (5’-end labeled) plus DNA2; 3, 
forked substrate (3’-end labeled) plus DNA2. Lanes 2 and 3 are the same as lanes 4 and 7 in 
Figure 1B. The positions of the intact 50-mer, cleavage product and markers (dT50, dT25 and 
dT12) are indicated.   
(B) RPA promotes 5’3’ degradation and inhibits 3’5’ degradation of a flapped DNA 
substrate by DNA2. 
Nuclease assays with DNA2 were performed using duplex DNA substrates containing 5’- or 3’-
ssDNA flap. RPA was added to the indicated concentration. The reactions were incubated for 1 
hr at 37 oC. The products were denatured by heat and resolved using 12% SequaGel and detected 
by autoradiography. The positions of markers are indicated.  
Figure S3. Resection mediated by BLM and DNA2 is endonucleolytic, requires RPA, and a 
cognate helicase.  
Nuclease reactions were performed using 5’-end labeled 50 bp DNA fragment.  
(A) BLM-DNA2 mediated resection in not exonucleolytic.  
(B) Requirement for RPA during resection.  
(C) and (D) RecQ4 (Q4), WRN (W) and RecQ5 (Q5) helicase do not substitute for BLM (B). 
The intrinsic nuclease activity of WRN was weakly evident (lanes 5 and 6, panel D). 
(E) Sgs1 helicase is inhibited by higher Mg2+ concentration. The percent of DNA unwound is 
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plotted as a function of Mg2+ concentration. The amount of substrate unwound was expressed as 
a percentage of total signal. Error bars indicate standard deviation from 3 independent 
experiments. 
Figure S4. MRN stimulates DNA unwinding by BLM and resection by EXO1.  
(A) Stimulation of BLM helicase by MRN. Lanes: 1, substrate; 2, MRN; 3, BLM; 4 BLM and 
MRN; , heat-denatured substrate. The positions of the intact (2.7 kbp) and unwound (ssDNA) 
substrate are indicated. 
(B) The percent of unwound substrate from experiments as shown in Figure 3A plotted as a 
function of MRN concentration. The amount of substrate unwound was expressed as a 
percentage of total signal. Error bars indicate standard deviation between 3 to 5 independent 
experiments. 
(C) MRN stimulates BLM-mediated unwinding of blunted ended DNA. Helicase reactions with 
BLM (0, 2.5, 5 and 10 nM) were performed using 3’-end labeled blunt-ended DNA. All 
reactions contained 10 nM RPA and 5 mM MgCl2. Lanes: 1-4, BLM alone; 5-8, BLM and MRN; 
9, substrate; , heat-denatured substrate. The positions of the intact (50 bp) and unwound (50 nt) 
substrate are indicated. 
(D) MRN stimulates BLM-mediated unwinding of 3’-tailed DNA. Helicase reactions were 
performed as described in (C) using 3’-end labeled tailed DNA (1.5 nM ends, 60 nM nt). Lanes: 
1-4, BLM alone; 5-8, BLM and MRN; 9, substrate; , heat-denatured substrate. 
(E) MRN and EXO1 resect DNA in the absence of ATP. All reactions contained 5 mM MgCl2. 
RPA was included when indicated. Lanes: 1-3, EXO1, 4-6, MRN and EXO1, 7-9, MRN, EXO1 
and RPA; 10-12, EXO1 and RPA. The positions of the intact substrate (2.7 kbp) and resection 
products are indicated.  
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(F) Stimulation of EXO1 by MRN is not species-specific. Where indicated, MRN was 
substituted with yeast MRX. All reactions contained 5 mM MgCl2 and 200 nM RPA. Lanes: 1-3, 
EXO1, 4-6, EXO1 and MRN; 7-9 and 10-12, EXO1 and MRX; 13-15, MRX. The positions of 
the intact substrate (2.7 kbp) and resection products are indicated.  
Figure S5. The use of Mn2+ to activate MRN nuclease blocks resection.   
Nuclease reactions with MRN, EXO1, BLM, DNA2 and RPA were performed using 3’-end 
labeled 2.7 kbp DNA. The concentrations of MRN, EXO1, BLM, DNA2 and RPA were 10 nM, 
2.5 nM, 10 nM, 4 nM and 200 nM respectively. The concentration of MgCl2 or MnCl2 is 
indicated. (A) Substitution of Mn2+ for Mg2+ inhibits resection:  Lanes: 1-6, reactions in Mg2+; 7-
15, reactions in Mn2+. (B) Addition of Mn2+ inhibits DNA end resection:  Lanes: 1-9, reactions in 
a fixed concentration of Mg2+ and various concentrations of Mn2+. The positions of intact 
substrate (2.7 kbp) and resection products are indicated. 
Figure S6. BLM increases the affinity of EXO1 for DNA ends but not the processivity.  
Processivity was measured as described in Materials and Methods.  
(A) Kinetics of EXO1 activity. Lanes: 1-5, no ssDNA added; 6-10, ssDNA added at 0 min; 11-
15, ssDNA added after 1 min pre-incubation.  
(B) BLM has no nuclease activity. Lanes: 1-5, time course with BLM alone. 
(C) Kinetics of EXO1 activity in the presence of BLM. Lanes: 1-5, no ssDNA added; 6-10, 
ssDNA added at 0 min; 11-15, ssDNA added after 1 min pre-incubation.  
The positions of DNA fragment corresponding to no degradation (3600 nt), the resection 
intermediates and markers (nt) are indicated. 
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